Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 28th March 2018
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New vaccine company to tackle FMDV in China
“Foot-and-mouth disease in swine is an epidemic that has a significant impact on animal husbandry and food safety."
Animal health leaders team up for new venture 

A joint venture to tackle foot-and-mouth disease (FMDV) in China has seen three leading animal health companies team up to form a new vaccine company.

The Shaanxi Meili Omni-Honesty Animal Health Co., Ltd is expected to focus on the research, development and manufacture of vaccines against FMDV, beginning in 2021. The total investment in the project amounts to 840 million yuan (around £94.5 million).

Launched at a groundbreaking ceremony at Airport New City in Xi’an, the company is a joint venture between Boehringer Ingelheim, Beijing KangMu Omni-Honesty Animal Health Products Co., Ltd (KMOH), and China Agricultural Vet. Bio. Science and Technology Co., Ltd (ZNWT).

Yuan Ximin, chairman of the new vaccine company, said: “Foot-and-mouth disease in swine is an epidemic that has a significant impact on animal husbandry and food safety. It is highly contagious and has a high mortality rate.

“The market is in urgent need of vaccines featuring the world’s top-level technology. I believe this project will drive transformation and upgrading of China’s animal vaccine industry, and it will also help improve economic benefits for Chinese farmers.”

The three companies each bring unique expertise to the venture; with Boehringer a leader in veterinary public health, ZNWT approved by the Ministry of Agriculture to produce the full set of vaccines against FMDV, and KMOH benefitting from extensive market channels across China.

Zhang Yunde, chairman and general manager of ZNWT, said the collaboration will lead to unprecedented advances in disease prevention and control, as well as vaccine technology and market growth.

Become a member or log in to add this story to your CPD history

Birmingham Dogs Home makes urgent appeal

News Story 1
 Birmingham Dogs Home has issued an urgent winter appeal as it faces more challenges over the Christmas period.

The rescue centre has seen a dramatic increase in dogs coming into its care, and is currently caring for over 200 dogs. With rising costs and dropping temperatures, the charity is calling for urgent support.

It costs the charity £6,000 per day to continue its work.

Fi Harrison, head of fundraising and communications, said: "It's heart-breaking for our team to see the conditions some dogs arrive in. We really are their last chance and hope of survival."

More information about the appeal can be found here. 

Click here for more...
News Shorts
Avian flu confirmed at premises in Cornwall

A case of highly pathogenic avian influenza H5N1 has been detected in commercial poultry at a premises near Rosudgeon, Cornwall.

All poultry on the infected site will be humanely culled, and a 3km protection zone and 10km surveillance zone have been put in place. Poultry and other captive birds in the 3km protection zone must be housed.

The case is the second avian flu case confirmed in commercial poultry this month. The H5N5 strain was detected in a premises near Hornsea, East Riding of Yorkshire, in early November. Before then, the disease had not been confirmed in captive birds in England since February.

The UK chief veterinary officer has urged bird keepers to remain alert and practise robust biosecurity.

A map of the disease control zones can be found here.